Biological mitral valve restenosis after replacement in rheumatic heart disease is a rare complication. This case illustrates venoarterial extracorporeal membrane oxygenation to facilitate transcatheter mitral valve replacement in a patient with suprasystemic pulmonary pressure and cardiogenic shock with multiorgan failure secondary to critical mitral stenosis of a bioprosthetic valve.
JACC Editor-in-Chief Julia Grapsa, MD, PhD, FACCCME Editor Nadeen N. Faza, MD, FACCAuthorsAssi Milwidsky, MDSharon Bruoha, MDRachel Clark, MDAzeem Latib, MDUlrich Jorde, MDImportant Dates
Date of Release: April 6, 2022Term of Approval/Date of CME/MOC/ECME Expiration: April 5 2023